Inventia Healthcare Limited Dapagliflozin Export Data — India (DGFT 2022–2026)

Name: Inventia Healthcare Limited Dapagliflozin Export Records India — #4 Exporter, 111 Shipments, $4.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Dapagliflozin

India Pharmaceutical Trade Intelligence

$49.5M254 Suppliers113 CountriesHS 30049099

ExportsIndia → CANADA25.9%India → IRAQ17.2%

ImportsGERMANY → India$59.4K BRAZIL → India$38.8K

#1 Supplier: AJANTA PHARMA

Inventia Healthcare Limited — Dapagliflozin Exporter #4 | $4.6M Trade Value | TransData Nexus | TransData Nexus

Inventia Healthcare Limited — Dapagliflozin Exporter Profile

Indian Pharmaceutical Exporter · #4 for Dapagliflozin · $4.6M export value · DGFT Verified

Inventia Healthcare Limited is the #4 Indian exporter of Dapagliflozin with $4.6M in export value and 111 verified shipments. Inventia Healthcare Limited holds a 9.3% market share in Dapagliflozin exports across 11 countries. The company exports 11 pharmaceutical products worth $36.5M across 6 therapeutic categories.

Inventia Healthcare Limited — Dapagliflozin Export Profile: Buyers & Destinations

Inventia Healthcare Limited Dapagliflozin export treemap — buyers and destination countries | TransData Nexus

Where Does Inventia Healthcare Limited Export Dapagliflozin?

Country	Value	Shipments	Share
CANADA	$2.2M	72	71.5%
PHILIPPINES	$438.9K	11	14.3%
MALAYSIA	$200.0K	10	6.5%
GAUTEMALA	$87.8K	2	2.9%
BOTSWANA

Who Are the Top Buyers of Dapagliflozin from Inventia Healthcare Limited?

Buyer	Country	Value	Orders
JAMP PHARMA CORPORATION	CANADA	$1.7M	57
JAMP PHARMA CORPORATION.	CANADA	$532.2K	15
UNILAB, INC.	PHILIPPINES	$200.0K	4
HOVID INC	PHILIPPINES	$138.0K	3
DKSH MALAYSIA SDN BHD	MALAYSIA	$100.0K	3
HOVID BHD	MALAYSIA	$100.0K	7
NOVOSWISS PHARMACEUTICALS, S.A	GAUTEMALA	$87.8K	2
HEALOL PHARMA CORPORATION	PHILIPPINES	$76.2K	3
FRANCISMED	BOTSWANA	$35.4K	2
DMD HEALTHCARE	ZIMBABWE	$34.9K	1

Inventia Healthcare Limited supplies Dapagliflozin to 16 buyers globally. The largest buyer is JAMP PHARMA CORPORATION (CANADA), followed by JAMP PHARMA CORPORATION. (CANADA) and UNILAB, INC. (PHILIPPINES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Dapagliflozin Formulations Does Inventia Healthcare Limited Export?

Product Description / Formulation	Value	Shipments
Dapagliflozin 10mg Tablet - 30's (BOTTLE	$137.8K	4
Dapagliflozin 10mg Tablet - 30's BOTTLE= NOS	$121.5K	3
Dapagliflozin 10 mg Tablet-100's BOTTLE= NOS	$100.0K	2
DAPAGLIFLOZIN 10 MG TABLET -30'S	$100.0K	2
ANDAMIL DAPAGLIFLOZIN TABLETS 10 MG (PHARMACEUTICALS PRODUCT)	$87.8K	2
DAPAGLIFLOZIN 5 MG TABLET -100'S	$87.1K	2
Dapagliflozin 5 mg Tablet-100's BOTTLE= NOS	$86.3K	2
Dapagliflozin 10 mg Tablet-500's BOTTLE= NOS	$85.8K	2
DAPAGLIFLOZIN 10 MG TABLET-500'S	$77.9K	2
DAPAGLIFLOZIN 10MG TABLET-500'S	$77.8K	2

Inventia Healthcare Limited exports 85 distinct Dapagliflozin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Dapagliflozin 10mg Tablet - 30's (BOTTLE with 4 shipments worth $137.8K.

How Does Inventia Healthcare Limited Compare to Nearest Dapagliflozin Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	AJANTA PHARMA LIMITED	$5.2M	103	4	$50.0K
3	ALEMBIC PHARMACEUTICALS LIMITED	$4.8M	95	3	$50.0K
4	INVENTIA HEALTHCARE LIMITED ★	$4.6M	111	11	$41.3K
5	CIPLA LIMITED	$3.3M	96	8	$34.2K
7	WATSON PHARMA PRIVATE LIMITED	$1.8M	63	6	$29.3K

Inventia Healthcare Limited ranks #4 among 254 Indian Dapagliflozin exporters. Average shipment value of $41.3K compared to the market average of $135.5K. The closest competitors by value are AJANTA PHARMA LIMITED and ALEMBIC PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Dapagliflozin Exports?

Port	Shipments	% Share
SAHAR AIR	1,003	19.7%
SAHAR AIR CARGO ACC (INBOM4)	791	15.5%
DELHI AIR CARGO ACC (INDEL4)	761	14.9%
DELHI AIR	612	12.0%
Bombay Air	194	3.8%
BANGALORE ACC (INBLR4)	189	3.7%
BANGALORE AIR	160	3.1%
NHAVA SHEVA SEA (INNSA1)	136	2.7%

Geopolitical & Trade Policy Impact on Inventia Healthcare Limited's Dapagliflozin Exports

Inventia Healthcare's extensive export operations are currently navigating a complex geopolitical landscape that presents both challenges and opportunities. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These logistical challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in supply chain management to mitigate potential delays and cost escalations. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced additional complexities for Indian pharmaceutical exporters. The imposition of tariffs on a broad range of imports, including pharmaceuticals, has raised concerns about cost competitiveness and market access. Companies like Inventia must navigate these policy shifts by exploring alternative markets and enhancing operational efficiencies to maintain their competitive edge. (apnews.com)

Conversely, the European Union's stringent regulatory frameworks, such as the Falsified Medicines Directive, necessitate rigorous compliance measures. While these regulations impose additional operational requirements, they also present an opportunity for companies with robust quality systems to differentiate themselves. Inventia's adherence to international quality standards positions it favorably to meet these regulatory demands and strengthen its presence in the European market.

Inventia Healthcare Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA and the European Medicines Agency intensifying their focus on manufacturing practices and product quality. For Indian exporters, this translates into the necessity for stringent compliance with Good Manufacturing Practices (GMP) and other regulatory standards.

Inventia Healthcare's manufacturing facility in Ambernath and its research and development center in Thane are accredited by the U.S. FDA, U.K. MHRA, and other stringent regulatory authorities. This compliance underscores the company's commitment to maintaining high-quality standards, facilitating access to both emerging and regulated markets. (platinumequity.com)

However, the broader Indian pharmaceutical sector faces challenges related to quality assurance, with instances of regulatory non-compliance affecting the industry's reputation. To mitigate these risks, companies like Inventia must continually invest in quality control systems, employee training, and process improvements to ensure sustained compliance and market trust.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Dapagliflozin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Inventia Healthcare Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 111 individual customs records matching Inventia Healthcare Limited exporting Dapagliflozin, covering 85 formulations to 11 countries via 16 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 113+ countries, 502+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Dapagliflozin

Dapagliflozin

Inventia Healthcare Limited — Dapagliflozin Exporter Profile

Inventia Healthcare Limited — Dapagliflozin Export Profile: Buyers & Destinations

Where Does Inventia Healthcare Limited Export Dapagliflozin?

Who Are the Top Buyers of Dapagliflozin from Inventia Healthcare Limited?

What Is India's Total Dapagliflozin Export Value and How Much Does Inventia Healthcare Limited Contribute?

What Is the Average Shipment Value for Inventia Healthcare Limited's Dapagliflozin Exports?

How Does Inventia Healthcare Limited Compare to Other Indian Dapagliflozin Exporters?

What Dapagliflozin Formulations Does Inventia Healthcare Limited Export?

Regulatory Requirements: Exporting Dapagliflozin to Key Markets

Canada — HC

How Does Inventia Healthcare Limited Compare to Nearest Dapagliflozin Exporters?

Which Indian Ports Ship Dapagliflozin Exports?

What Other Advanced Diabetes Medications Products Does Inventia Healthcare Limited Export?

Geopolitical & Trade Policy Impact on Inventia Healthcare Limited's Dapagliflozin Exports

Inventia Healthcare Limited — Regulatory Compliance & Quality Standards

About Inventia Healthcare Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Dapagliflozin Export Data from Inventia Healthcare Limited

Dapagliflozin Stats

Company Overview

Top Products by Inventia Healthcare Limited

Related Analysis

Need Detailed Export Data?

Data Source